Inorganic/organic
hybrid nanosystems have been increasingly developed
for their versatility and efficacy at overcoming obstacles not readily
surmounted by nonhybridized counterparts. Currently, hybrid nanosystems
are implemented for gene therapy, drug delivery, and phototherapy
in addition to tissue regeneration, vaccines, antibacterials, biomolecule
detection, imaging probes, and theranostics. Though diverse, these
nanosystems can be classified according to foundational inorganic/organic
components, accessory moieties, and architecture of hybridization.
Within this Review, we begin by providing a historical context for
the development of biomedical hybrid nanosystems before describing
the properties, synthesis, and characterization of their component
building blocks. Afterward, we introduce the architectures of hybridization
and highlight recent biomedical nanosystem developments by area of
application, emphasizing hybrids of distinctive utility and innovation.
Finally, we draw attention to ongoing clinical trials before recapping
our discussion of hybrid nanosystems and providing a perspective on
the future of the field.